Cargando…
Vaccine Development Against Leishmania donovani
Visceral leishmaniasis (VL) caused by Leishmania donovani and Leishmania infantum/chagasi represents the second most challenging infectious disease worldwide, leading to nearly 500,000 new cases and 60,000 deaths annually. Zoonotic VL caused by L. infantum is a re-emergent canid zoonoses which repre...
Autores principales: | Das, Amrita, Ali, Nahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351671/ https://www.ncbi.nlm.nih.gov/pubmed/22615707 http://dx.doi.org/10.3389/fimmu.2012.00099 |
Ejemplares similares
-
Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani : Evidence for Antigen Synergy and Protection
por: Das, Amrita, et al.
Publicado: (2014) -
Correction: Combining Cationic Liposomal Delivery with MPL-TDM for Cysteine Protease Cocktail Vaccination against Leishmania donovani: Evidence for Antigen Synergy and Protection
por: Das, Amrita, et al.
Publicado: (2015) -
HO-3867 Induces ROS-Dependent Stress Response and Apoptotic Cell Death in Leishmania donovani
por: Das, Amrita, et al.
Publicado: (2021) -
Potency, Efficacy and Durability of DNA/DNA, DNA/Protein and Protein/Protein Based Vaccination Using gp63 Against Leishmania donovani in BALB/c Mice
por: Mazumder, Saumyabrata, et al.
Publicado: (2011) -
Heterologous Immunization With Defined RNA and Subunit Vaccines Enhances T Cell Responses That Protect Against Leishmania donovani
por: Duthie, Malcolm S., et al.
Publicado: (2018)